Anti-CD4 antibody [RPA-T4] (FITC) GTX74817 from GeneTex | Biocompare.com

Supplier Images

Anti-CD4 antibody [RPA-T4] (FITC)
Anti-CD4 antibody [RPA-T4] (FITC)

Be the first to write a review!

Citations:

Supplier Page from
GeneTex for
Anti-CD4 antibody [RPA-T4] (FITC)

Description

GeneTex's Anti-CD4 antibody [RPA-T4] (FITC) is a Mouse Monoclonal antibody. The Anti-CD4 antibody [RPA-T4] (FITC) was generated using CD4 molecule, CD4mut as the antigen. The Anti-CD4 antibody [RPA-T4] (FITC) from GeneTex is a Mouse Monoclonal antibody to CD4. The Anti-CD4 antibody [RPA-T4] (FITC) Recognizes Human. The Anti-CD4 antibody [RPA-T4] (FITC) has been validated for the following Applications: FCM

Product Specs
ItemAnti-CD4 antibody [RPA-T4] (FITC)
CompanyGeneTex
Price $349.00Supplier Page
Catalog NumberGTX74817
Quantity100 test
Format10mM NaH₂PO₄, 150mM NaCl, 0.1% Gelatin, 0.09% Sodium azide
ApplicationsFCM
Conjugate/TagFluorescein isothiocyanate (FITC)
Concentration0.2mg/ml
Antibody TypePrimary Antibodies
ReactivityHuman
IsotypeIgG1
Molecular Weight51
TargetCD4
HostMouse
PurityPurified by affinity chromatography
CloneRPA-T4
ClonalityMonoclonal
NCBI Full Gene NameCD4 molecule
Gene NameCD4
ImmunogenHuman PHA blasts
NCBI Gene AliasesCD4 molecule, CD4mut, IMD79, CD4mut, T4, OKT4D, Leu-3
Research AreaImmunology, Infectious Diseases, Tumor Markers

Add to Compare List

GeneTex

GeneTex

GeneTex, Inc. 2456 Alton Parkway

Irvine, California 92606

United States

Phone: 1-877-GeneTex (436-3839) or 949-553-1900
Fax: 949-309-2888

Company Profile

Website: http://www.genetex.com

(1) Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challengeNature medicineOctober 1, 2014Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, et al.

(2) Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumabJournal of virologyApril 1, 2011Toma J, Weinheimer SP, Stawiski E, Whitcomb JM, Lewis ST, Petropoulos CJ, Huang W.

(3) CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletionJournal of immunology (Baltimore, Md. : 1950)December 1, 2010Porter KA, Kelley LN, Nekorchuk MD, Jones JH, Hahn AB, de Noronha CM, Harton JA, Duus KM.

(4) The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulumJournal of virologyMay 1, 2010Hsieh SC, Tsai WY, Wang WK.

(5) Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytesVirologyNovember 10, 2009Decker JM, Zammit KP, Easlick JL, Santiago ML, Bonenberger D, Hahn BH, Kutsch O, Bibollet-Ruche F.

(6) Modulation of CD1d-restricted NKT cell responses by CD4Journal of leukocyte biologyDecember 1, 2007Chen X, Wang X, Besra GS, Gumperz JE.

(7) CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cellsBloodJuly 1, 2007Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, et al.

(8) Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsyCirculationMarch 15, 1995Deng MC, Bell S, Huie P, Pinto F, Hunt SA, Stinson EB, Sibley R, Hall BM, Valantine HA.

Be the First to Write a Review!